Anatomic Stage II Breast Cancer AJCC v8 Recruiting Phase 1 Trials for Daunorubicin (DB00694)

Also known as: Anatomic Stage 2 Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109622 (Anatomic Stage II Breast Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04081389Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerTreatment